PL375255A1 - Prodrugs of proton pump inhibitors - Google Patents

Prodrugs of proton pump inhibitors

Info

Publication number
PL375255A1
PL375255A1 PL03375255A PL37525503A PL375255A1 PL 375255 A1 PL375255 A1 PL 375255A1 PL 03375255 A PL03375255 A PL 03375255A PL 37525503 A PL37525503 A PL 37525503A PL 375255 A1 PL375255 A1 PL 375255A1
Authority
PL
Poland
Prior art keywords
prodrugs
proton pump
pump inhibitors
bioavailability
formulas
Prior art date
Application number
PL03375255A
Other languages
English (en)
Polish (pl)
Inventor
Michael E. Garst
George Sachs
Jai Moo Shin
Original Assignee
Winston Pharmaceuticals Llc
The Regents Of The University Of California
U.S.Government Represented By The Department Of Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winston Pharmaceuticals Llc, The Regents Of The University Of California, U.S.Government Represented By The Department Of Veterans Affairs filed Critical Winston Pharmaceuticals Llc
Publication of PL375255A1 publication Critical patent/PL375255A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
PL03375255A 2002-07-19 2003-07-15 Prodrugs of proton pump inhibitors PL375255A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39745902P 2002-07-19 2002-07-19

Publications (1)

Publication Number Publication Date
PL375255A1 true PL375255A1 (en) 2005-11-28

Family

ID=30771064

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375255A PL375255A1 (en) 2002-07-19 2003-07-15 Prodrugs of proton pump inhibitors

Country Status (22)

Country Link
US (3) US6897227B2 (enExample)
EP (1) EP1556371B1 (enExample)
JP (1) JP4463103B2 (enExample)
KR (2) KR100822981B1 (enExample)
AT (1) ATE323695T1 (enExample)
AU (1) AU2003259154B2 (enExample)
BR (1) BR0312802A (enExample)
CA (1) CA2492718C (enExample)
CO (1) CO5690576A2 (enExample)
DE (1) DE60304726T2 (enExample)
DK (1) DK1556371T3 (enExample)
ES (1) ES2263028T3 (enExample)
IL (1) IL166371A0 (enExample)
MX (1) MXPA05000657A (enExample)
NO (1) NO20050801L (enExample)
NZ (1) NZ538221A (enExample)
PL (1) PL375255A1 (enExample)
PT (1) PT1556371E (enExample)
RU (1) RU2292342C2 (enExample)
TW (1) TW200502231A (enExample)
WO (1) WO2004009583A2 (enExample)
ZA (1) ZA200501116B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU2003254282A1 (en) * 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
EP1644352A1 (en) * 2003-07-15 2006-04-12 Allergan, Inc. Process for preparing isomerically pure prodrugs of proton pump inhibitors
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
CA2557471A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors
EP1715861A2 (en) * 2004-02-18 2006-11-02 Allergan, Inc. Compositions comprising prodrugs of proton pump inhibitors
BRPI0507796A (pt) * 2004-03-11 2007-07-17 Allergan Inc métodos e composições para o tratamento de condições relacionadas com a secreção de ácido gástrico
ATE437869T1 (de) 2004-04-28 2009-08-15 Hetero Drugs Ltd Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
WO2007073301A1 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Benzoimidazole derivatives as prodrugs of proton pump inhibitors
WO2007081871A1 (en) * 2006-01-10 2007-07-19 Allergan, Inc. Therapeutic salt compositions of sulfonyl ester prodrugs of proton pump inhibitors and methods for their preparation
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
US20070293543A1 (en) * 2006-06-19 2007-12-20 Edward Lee THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
US20100113524A1 (en) * 2006-09-19 2010-05-06 Garst Michael E Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
EP2193518A4 (en) * 2007-10-05 2010-10-27 Lg Electronics Inc PLASMA DISPLAY DEVICE
KR20090035195A (ko) * 2007-10-05 2009-04-09 엘지전자 주식회사 플라즈마 디스플레이 장치
KR100895333B1 (ko) * 2007-11-01 2009-05-07 엘지전자 주식회사 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치
WO2012051036A1 (en) 2010-10-11 2012-04-19 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as crth2 antagonists
WO2012087872A1 (en) 2010-12-23 2012-06-28 Merck Sharp & Dohme Corp. Quinolines and aza-quinolines as crth2 receptor modulators
KR20130133219A (ko) 2010-12-23 2013-12-06 머크 샤프 앤드 돔 코포레이션 Crth₂ 수용체 조절제로서의 퀴녹살린 및 아자-퀴녹살린
EP3242664A4 (en) * 2015-01-09 2018-06-20 The Regents of the University of California Compositions and methods for treating gastrointestinal infections
CN108997177A (zh) * 2018-09-04 2018-12-14 邵阳学院 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US430042A (en) * 1890-06-10 Valve
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
US4758597A (en) * 1987-05-15 1988-07-19 University Patents, Inc. Carenadiol and derivatives
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5045522A (en) * 1990-03-27 1991-09-03 Phillips Petroleum Company Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams
PL166209B1 (pl) * 1990-06-20 1995-04-28 Astra Ab Sposób wytwarzania nowych pochodnych benzimidazolu PL
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
NZ288609A (en) * 1994-06-10 1998-12-23 Byk Gulden Lomberg Chem Fab Substituted (4-thiopyridinyl) methylthio-benzimidazole (or 1h-imidazo-[2,3-b]-pyridine) and medicaments
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
CN100396675C (zh) * 1998-08-10 2008-06-25 加利福尼亚州大学董事会 质子泵抑制剂的前药
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
EP1535921A1 (en) * 1998-08-12 2005-06-01 Gilead Sciences, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6599167B2 (en) * 2000-09-27 2003-07-29 Glenn Waltz Game call holder and amplifying device
US20040039027A1 (en) 2000-10-12 2004-02-26 Keiji Kamiyama Benzimidazole compounds, process for producing the same and use thereof

Also Published As

Publication number Publication date
JP2005536519A (ja) 2005-12-02
AU2003259154B2 (en) 2006-12-07
US20040102484A1 (en) 2004-05-27
WO2004009583A3 (en) 2004-03-18
ATE323695T1 (de) 2006-05-15
NO20050801L (no) 2005-02-15
WO2004009583A2 (en) 2004-01-29
DE60304726T2 (de) 2007-08-09
RU2005105564A (ru) 2005-10-10
KR100788778B1 (ko) 2007-12-27
US20050182101A1 (en) 2005-08-18
DE60304726D1 (de) 2006-05-24
DK1556371T3 (da) 2006-08-21
NZ538221A (en) 2006-11-30
JP4463103B2 (ja) 2010-05-12
US6897227B2 (en) 2005-05-24
ES2263028T3 (es) 2006-12-01
AU2003259154A1 (en) 2004-02-09
US20050143423A1 (en) 2005-06-30
KR20050047078A (ko) 2005-05-19
RU2292342C2 (ru) 2007-01-27
ZA200501116B (en) 2006-11-29
KR20070005029A (ko) 2007-01-09
HK1079207A1 (en) 2006-03-31
MXPA05000657A (es) 2005-08-19
TW200502231A (en) 2005-01-16
EP1556371B1 (en) 2006-04-19
IL166371A0 (en) 2006-01-16
CA2492718A1 (en) 2004-01-29
AU2003259154C1 (en) 2004-02-09
CA2492718C (en) 2010-12-21
EP1556371A2 (en) 2005-07-27
CO5690576A2 (es) 2006-10-31
BR0312802A (pt) 2005-04-19
KR100822981B1 (ko) 2008-04-16
PT1556371E (pt) 2006-09-29

Similar Documents

Publication Publication Date Title
TW200502231A (en) Prodrugs of proton pump inhibitors
PL361355A1 (en) Phenylglycine derivatives
AU2003255845A1 (en) Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
EP2289894A3 (en) Pyrrolo-triazine compounds useful as kinase inhibitors
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
MXPA03004794A (es) Derivados de acido mandelico y su uso como inhibidores de trombina.
IL175953A (en) Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
AP2000001900A0 (en) Halogeneted amidino amino acid derivatives useful as nitric oxide synthase inhibitors.
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
MXPA05009282A (es) Derivados de anilina sustituidos.
AP2002002466A0 (en) 3-heterocycliylpropanohydroxamic acid PCP INHIBITORS.
DK1696911T3 (da) Intranasale sammensætninger
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
DE60324703D1 (de) Barbitursäure derivaten.
EA200101150A1 (ru) Раствор прукалоприда для перорального применения
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
TW200509921A (en) Alkaline salts
TW200733963A (en) Cough inhibitor
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
SG171472A1 (en) Substituted aniline derivatives
NO20030375D0 (no) N-substituerte 1-amino-1,1-dialkylkarboksylsyrederivater
ATE491709T1 (de) Pyrrolidinohydrochinazoline

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)